Clinical Trials Logo

Fetal Alcohol Spectrum Disorders clinical trials

View clinical trials related to Fetal Alcohol Spectrum Disorders.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03494738 Active, not recruiting - Clinical trials for Fetal Alcohol Spectrum Disorders

Development of an Epigenetic Biomarker for Prediction of Fetal Alcohol Spectrum Disorder

Start date: April 12, 2018
Phase:
Study type: Observational

The objective of the study is to validate epigenetic changes as biomarkers in a prospective sampling of newborn blood samples collected at birth (umbilical cord blood) and during routine screening (heel stick blood) in newborns concurrently tested for alcohol exposure levels by PEth blood spot testing.

NCT ID: NCT01536184 Active, not recruiting - Clinical trials for Fetal Alcohol Spectrum Disorder

Evaluating the Effectiveness of an Attachment-Focused Intervention in Preschool Children With FASD

Start date: March 2012
Phase: N/A
Study type: Interventional

Study Summary: This study is being conducted in order to rigorously evaluate the real-world effectiveness of a publicly-funded, home-based, attachment-focused intervention Circle of Security (COS) Family Intervention Model (Marvin) in improving caregiving and child outcomes in families who have children with Fetal Alcohol Spectrum Disorder (FASD) or who are at-risk for FASD, as delivered under routine practice conditions. Hypothesis: At post-test (after 36 sessions and 3-month follow-up), compared to a wait-list control group receiving standard services, the treatment group receiving COS will show greater improvement in caregiver behaviour, as well as child emotional and behavioural outcomes.

NCT ID: NCT00996528 Active, not recruiting - HIV Clinical Trials

Neighborhood Alcohol & HIV Prevention in South African Townships (Philani)

Start date: September 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to test a mother-to-mother intervention during pregnancy and after delivery with mothers in South Africa, most of whom are at risk delivering babies with fetal alcohol syndrome, babies that are underweight, or babies that are infected with HIV from an HIV-positive mother. The investigators hypothesize that the intervention will reduce the chance of these three health outcomes occurring in the babies and improve the health of the mother.